Michael Reed, PhD, is a Managing Partner at NaviDx, Libertas Global, and VentureWell, leading strategic consulting practices and initiatives aimed at enhancing patient care, free trade, and accelerating the development of innovative diagnostics. With a background in molecular biology and biochemistry, Michael has held various leadership positions in companies like OraSure Technologies and Danaher Corporation, contributing to the launch of numerous diagnostic products.
October, 2022 - present